Beximco Pharma gets license for oral anti-Covid drug | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Multimedia
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Sunday
December 10, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Multimedia
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
SUNDAY, DECEMBER 10, 2023
Beximco Pharma gets license for oral anti-Covid drug

Covid-19 in Bangladesh

TBS Report
20 January, 2022, 02:40 pm
Last modified: 20 January, 2022, 06:05 pm

Related News

  • Beximco suffers Tk70cr loss in September quarter
  • Beximco Pharma revenue rose 14% in July-Sept
  • Beximco Green Sukuk: A fixed income opportunity overlooked
  • Beximco completes two projects financed by Sukuk fund
  • Beximco Pharma's profit falls 15% in Q3 FY23

Beximco Pharma gets license for oral anti-Covid drug

The company is expected to start domestic distribution and export from the end of 2022

TBS Report
20 January, 2022, 02:40 pm
Last modified: 20 January, 2022, 06:05 pm
Photo: Courtesy
Photo: Courtesy

Beximco Pharmaceuticals Limited has become the first Bangladeshi company to get permission to produce "molnupiravir," an oral drug for the treatment of Covid-19.

The United Nations-backed Medicines Patent Pool (MPP) granted a sub-license to Beximco Pharma for the local production of the oral drug originally developed by MSD, a trade name of Merck and Co Inc.

The partnership with Beximco was announced after the MPP expanded its network of partnered generic manufacturers, said a press release on Thursday.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The sub-license agreement is a result of the voluntary licensing agreement signed by the MPP and MSD in October 2021 to facilitate affordable global access for molnupiravir, which MSD is developing in partnership with Ridgeback Biotherapeutics.

Under this agreement, MPP may sub-license the production of the drug to global generic drug manufacturers to ensure a steady supply in different regions of the world. 

Molnupiravir is an oral antiviral to treat symptomatic Covid-19, which received conditional marketing authorisation in the UK from the UK Medicines and Healthcare Regulatory Agency on 4 November and received emergency use authorisation in the US from the US Food and Drug Administration on 23 December last year.

Beximco Pharma will manufacture molnupiravir in Bangladesh and is expected to start domestic distribution and export from the end of 2022, following successful technology transfer and manufacturing regulatory approvals under the license from MPP.

The company will continue to sell its own generic version of molnupiravir (Emorivir), as announced on 9 November 2021, under the World Trade Organization's Least Developed Country (LDC) waiver in the meantime.

Top News

Molnupiravir / Beximco / Beximco Pharmaceuticals / Beximco Pharma / Covid oral drug

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Two-thirds of LPG sellers hold on to bulk importers to stay afloat in dollar crisis
    Two-thirds of LPG sellers hold on to bulk importers to stay afloat in dollar crisis
  • Adverse impact of geopolitics taking toll on Bangladesh's economy: FBCCI president
    Adverse impact of geopolitics taking toll on Bangladesh's economy: FBCCI president
  • Bangladesh Securities and Exchange Commission (BSEC) Chairman Prof Shibli Rubayat-Ul-Islam. TBS Sketch
    Floor price to remain until election: BSEC chairman

MOST VIEWED

  • Buyer's rep removes sanction clause from RMG LC
    Buyer's rep removes sanction clause from RMG LC
  • Photo: Collected
    Dhaka expressway construction crane hits train; rail link with capital snapped
  • Infographic: TBS
    Automatic fuel oil pricing from March in Bangladesh
  • The company signed an agreement to this effect with BEPZA at BEPZA Complex, Dhaka on 7 December. Photo: Courtesy
    Chinese company to set up pharma ingredients factory in Bepza EZ
  • Infograph: TBS
    RMG exports to US fall 24.75% in Jan-Oct
  • One report says the suspects were stripped to ensure they were not carrying weapons - EMANUEL FABIAN/X/TWITTER
    Palestinians detained by Israel in Gaza blindfolded, stripped to underwear

Related News

  • Beximco suffers Tk70cr loss in September quarter
  • Beximco Pharma revenue rose 14% in July-Sept
  • Beximco Green Sukuk: A fixed income opportunity overlooked
  • Beximco completes two projects financed by Sukuk fund
  • Beximco Pharma's profit falls 15% in Q3 FY23

Features

Say hello to my little friend: Scarface turns 40

Say hello to my little friend: Scarface turns 40

7h | Features
Tuhin Bin Salam has been at the helm of the business since his father died in 2017. Photo: Nayem Ali

60-year legacy: A chronicle of Salam Stamp Centre

18h | Panorama
Bangladesh now has 19 GI-certified products. What changed?

Bangladesh now has 19 GI-certified products. What changed?

1d | Panorama
Illustration: TBS

How financial institutions can help transition to net zero

1d | Panorama

More Videos from TBS

Cricket icon and ‘Tied Test’ hero Joe Solomon dies at 93

Cricket icon and ‘Tied Test’ hero Joe Solomon dies at 93

5h | TBS SPORTS
Onion prices skyrocketed due to India's export ban

Onion prices skyrocketed due to India's export ban

6h | TBS Today
Most capped footballers in professional football

Most capped footballers in professional football

7h | TBS SPORTS
How to overcome dollar crisis

How to overcome dollar crisis

8h | TBS Round Table
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]